Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000899140-25-000860·Hein Park Capital Management LP
Schedule 13D ownership disclosure
Keenova Therapeutics PLC
Common Stock, par value $0.01 per share · CUSIP: G5890A102
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hein Park Capital Management LPReported CIK 0001826937
Shares: 1,955,827 · Class: 4.9%
- Hein Park Capital Management GP LLC
Shares: 1,955,827 · Class: 4.9%
- Courtney W. Carson
Shares: 1,955,827 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-25-000860
- Form type
- SCHEDULE 13D/A
- Filer
- Hein Park Capital Management LP
- CIK
- CIK 1826937
- Filed
- Aug 04, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13D beneficial ownership